Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $879.44 | 13 | 90.3% |
| Education | $94.99 | 1 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $124.55 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $121.80 | 1 | $0 (2018) |
| Relypsa, Inc. | $121.80 | 1 | $0 (2019) |
| Shire North American Group Inc | $121.80 | 1 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $104.76 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $94.99 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $74.62 | 1 | $0 (2018) |
| NxStage Medical, Inc. | $72.59 | 1 | $0 (2019) |
| Boston Scientific Corporation | $42.89 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $30.83 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88.14 | 3 | Alexion Pharmaceuticals, Inc. ($30.83) |
| 2023 | $36.25 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($23.39) |
| 2019 | $454.07 | 5 | Relypsa, Inc. ($121.80) |
| 2018 | $271.42 | 3 | Melinta Therapeutics, Inc. ($121.80) |
| 2017 | $124.55 | 1 | Astellas Pharma US Inc ($124.55) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/11/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.83 | General |
| 04/12/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: TRANSPLANTATION | ||||||
| 10/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.86 | General |
| 09/16/2019 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2019 | Boston Scientific Corporation | RESONATE (Device) | Food and Beverage | In-kind items and services | $42.89 | General |
| Category: TACHY | ||||||
| 05/14/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $72.59 | General |
| Category: Nephrology | ||||||
| 02/13/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $121.80 | General |
| Category: Hyperkalemia | ||||||
| 02/07/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $121.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/02/2018 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | Cash or cash equivalent | $121.80 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/21/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Immunosuppressant | ||||||
| 03/21/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $74.62 | General |
| Category: Cardiovascular | ||||||
| 02/15/2017 | Astellas Pharma US Inc | Astagraf XL (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 189 | 468 | $258,251 | $39,265 |
| 2022 | 3 | 117 | 265 | $136,159 | $21,462 |
| 2021 | 4 | 188 | 402 | $251,651 | $33,854 |
| 2020 | 4 | 199 | 440 | $259,632 | $34,085 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 112 | 293 | $98,809 | $21,421 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 125 | $93,500 | $12,147 | 13.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 27 | $47,358 | $3,539 | 7.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 23 | $18,584 | $2,158 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 83 | 187 | $63,731 | $14,021 | 22.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 64 | $47,872 | $5,197 | 10.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 14 | $24,556 | $2,244 | 9.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 108 | 246 | $85,385 | $18,617 | 21.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 106 | $78,438 | $9,158 | 11.7% |
| 50200 | Needle biopsy of kidney, accessed through the skin | Facility | 2021 | 28 | 35 | $61,695 | $3,389 | 5.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $26,133 | $2,689 | 10.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 114 | 261 | $85,861 | $16,178 | 18.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 132 | $93,900 | $11,594 | 12.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $31,977 | $3,422 | 10.7% |
| 50200 | Needle biopsy of kidney, accessed through the skin | Facility | 2020 | 28 | 28 | $47,894 | $2,891 | 6.0% |
About Dr. Thuy Le, MD
Dr. Thuy Le, MD is a Nephrology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1578859849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thuy Le, MD has received a total of $974.43 in payments from pharmaceutical and medical device companies, with $88.14 received in 2024. These payments were reported across 14 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($879.44).
As a Medicare-enrolled provider, Le has provided services to 693 Medicare beneficiaries, totaling 1,575 services with total Medicare billing of $128,666. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Portland, OR
- Active Since 06/24/2011
- Last Updated 02/22/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578859849
Products in Payments
- Astagraf XL (Drug) $124.55
- NATPARA (PARATHYROID HORMONE) (Drug) $121.80
- Vabomere (Drug) $121.80
- Veltassa (Drug) $121.80
- THYMOGLOBULIN (Drug) $94.99
- Envarsus XR (SP) (Drug) $75.00
- ELIQUIS (Drug) $74.62
- SYSTEM ONE (Device) $72.59
- RESONATE (Device) $42.89
- ENVARSUS (Drug) $29.76
- PREVYMIS (Drug) $27.55
- LIVTENCITY (Drug) $23.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Portland
Arjang Djamali, Md, MD
Nephrology — Payments: $68,391
Dr. Robert Provenzano, Md, MD
Nephrology — Payments: $45,008
David Ellison, Md, MD
Nephrology — Payments: $27,575
Dr. Shehzad Rehman, M.d, M.D
Nephrology — Payments: $6,989
Dr. Ioan Cosma, Md, MD
Nephrology — Payments: $3,794
Abd Assalam Qannus, M.d, M.D
Nephrology — Payments: $2,602